Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: A meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 5, 2014, Pages 756-764

  Wanders, Linda K ^a,b   Dekker, Evelien ^b   Pullens, Bo ^a,b   Bassett, Paul ^c   Travis, Simon P L ^a   East, James E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Statsconsultancy   (United Kingdom)

Author keywords

Colonoscopy; IBD; Inflammatory Bowel Diseases; Neoplasm; Surveillance; UC

Indexed keywords

ADENOMA; ADENOMATOUS POLYP; ARTICLE; CANCER INCIDENCE; CANCER RISK; COLITIS; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DIGESTIVE SYSTEM INFLAMMATION; DYSPLASIA; ENDOSCOPIC SURGERY; FOLLOW UP; HUMAN; INFLAMMATORY BOWEL DISEASE; META ANALYSIS; POLYPOID DYSPLASIA; PRIMARY SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS; ADENOCARCINOMA; COLONIC NEOPLASMS; COMPLICATION; RISK ASSESSMENT;

ADENOCARCINOMA; ADENOMA; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; HUMANS; RISK ASSESSMENT;

EID: 84898784567     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.07.024     Document Type: Article

References (43)

1. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
2. Herrinton L.J., Liu L., Levin T.R., et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012, 143:382-389.
3. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990, 323:1228-1233.
4. Jess T., Rungoe C., Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012, 10:639-645.
5. Jess T., Simonsen J., Jorgensen K.T., et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012, 143:375-381.
6. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003, 18(Suppl 2):1-5.
7. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004, 126:451-459.
8. Lakatos L., Mester G., Erdelyi Z., et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006, 12:205-211.
9. Leidenius M., Kellokumpu I., Husa A., et al. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut 1991, 32:1521-1525.
10. Ullman T., Croog V., Harpaz N., et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003, 125:1311-1319.
11. Lennard-Jones J.E., Morson B.C., Ritchie J.K., et al. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983, 2:149-152.
12. Mueller E., Vieth M., Stolte M., et al. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol 1999, 30:898-905.
13. Bernstein C.N. ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy?. Gastroenterology 1999, 117:1488-1492.
14. Neumann H., Vieth M., Langner C., et al. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 2011, 17:3184-3191.
15. Rutter M., Bernstein C., Matsumoto T., et al. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 2004, 36:1109-1114.
16. Farraye F.A., Waye J.D., Moscandrew M., et al. Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia associated lesions or masses in inflammatory bowel disease: an internet-based study. Gastrointest Endosc 2007, 66:519-529.
17. Lennard-Jones J.E., Melville D.M., Morson B.C., et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990, 31:800-806.
18. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
19. Thomas T., Abrams K.A., Robinson R.J., et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007, 25:657-668.
20. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
21. National Institute for Health and Clinical Excellence. Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas. Available at:. Accessed January 5, 2010. http://www.nice.org.uk/guidance/CG118.
22. Van Assche G., Dignass A., Bokemeyer B., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013, 7:1-33.
23. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting-Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
24. Wells GA, Shea B, O'Connell D, etal. The New Castle Ottowa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. Available at:. Accessed January 10, 2012. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
25. Desai T.K., Krishnan K., Samala N., et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut 2012, 61:970-976.
26. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
27. Jess T., Loftus E.V., Velayos F.S., et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis 2006, 12:669-676.
28. Rubin P.H., Friedman S., Harpaz N., et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999, 117:1295-1300.
29. Blonski W., Kundu R., Furth E.F., et al. High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis. Scand J Gastroenterol 2008, 43:817-820.
30. Goldstone R., Itzkowitz S., Harpaz N., et al. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. Gastrointest Endosc 2011, 74:1087-1093.
31. Kisiel J.B., Loftus E.V., Harmsen W.S., et al. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis 2012, 18:226-235.
32. Medlicott S.A., Jewell L.D., Price L., et al. Conservative management of small adenomata in ulcerative colitis. Am J Gastroenterol 1997, 92:2094-2098.
33. Odze R.D., Farraye F.A., Hecht J.L., et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004, 2:534-541.
34. Pekow J.R., Hetzel J.T., Rothe J.A., et al. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis 2010, 16:1352-1356.
35. Rozen P., Baratz M., Fefer F., et al. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995, 108:1361-1370.
36. Vieth M., Behrens H., Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006, 55:1151-1155.
37. Zisman T.L., Bronner M.P., Rulyak S., et al. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis 2012, 18:2240-2246.
38. Hurlstone D.P., Sanders D.S., Atkinson R., et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?. Gut 2007, 56:838-846.
39. van Schaik F.D., Mooiweer E., van der Have M., et al. Adenomas in patients with inflammatory bowel disease are associated with an increased risk of advanced neoplasia. Inflamm Bowel Dis 2013, 19:342-349.
40. Herrinton L.J., Liu L., Fireman B., et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology 2009, 137:502-511.
41. Soderlund S., Brandt L., Lapidus A., et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009, 136:1561-1567.
42. Wu L., Li P., Wu J., et al. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials. Colorectal Dis 2012, 14:416-420.
43. Soetikno R., Subramanian V., Kaltenbach T., et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013, 144:1349-1352.